Nucleoside Antimetabolite/Analog
Nucleoside antimetabolites and analogs are compounds that mimic natural nucleosides and are incorporated into DNA during replication, leading to chain termination or the inhibition of DNA synthesis. These compounds are widely used as chemotherapeutic agents in the treatment of cancer and viral infections. By disrupting DNA synthesis, nucleoside analogs induce cell cycle arrest and apoptosis. At CymitQuimica, we provide a wide range of high-quality nucleoside antimetabolites and analogs to support your research in cancer treatment, antiviral therapy, and DNA replication.
Found 1388 products of "Nucleoside Antimetabolite/Analog"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5'-O-Benzoyl-3'-O-(4-methoxybenzyl)-2'-O,4'-C-methyleneuridine
<p>5’-O-Benzoyl-3’-O-(4-methoxybenzyl)-2’-O,4’-C-methyleneuridine is a purine nucleoside analog with broad antitumor activity, primarily targeting indolent</p>Formula:C25H24N2O8Color and Shape:SolidMolecular weight:480.47N4-(3,3,3-Trifluoropropanoyl)cytidine
<p>N4-(3,3,3-Trifluoropropanoyl)cytidine, a cytidine analog, inhibits DNA methyltransferases, possibly anti-metabolic and anti-cancer.</p>Formula:C12H14F3N3O6Color and Shape:SolidMolecular weight:353.256-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
<p>6-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine, a purine nucleoside analogue, exhibits broad antitumor activity by</p>Formula:C15H17N5O6Color and Shape:SolidMolecular weight:363.336-Amino-4-hydrozino-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
<p>6-Amino-4-hydrozino-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine, a pyrimidine nucleoside analog, boasts a broad spectrum of biochemical and</p>Formula:C10H17N7O3Color and Shape:SolidMolecular weight:283.292'-O-Methyladenosine 5'-monophosphate triethyl ammonium
<p>2’-O-Methyladenosine 5’-monophosphate triethyl ammonium is an adenosine analog.</p>Formula:C11H14N5O7P2Color and Shape:SolidMolecular weight:359.231-(β-D-Xylofuranosyl)-N6-(m-trifluoromethylbenzyl)adenine
<p>1-(β-D-Xylofuranosyl)-N6-(m-trifluoromethylbenzyl)adenine is an adenosine analog.</p>Formula:C18H18F3N5O4Color and Shape:SolidMolecular weight:425.36m7GpppUmpG
CAS:<p>m7GpppUmpG, a trinucleotide cap analogue, enables RNA synthesis with cap 0 or 1 structures.</p>Formula:C31H42N12O26P4Color and Shape:SolidMolecular weight:1122.63N1-Methyl-2'-O-(2-methoxyethyl) adenosine
<p>N1-Methyl-2’-O-(2-methoxyethyl) adenosine, a purine nucleoside analog, exhibits broad antitumor effects, particularly against indolent lymphoid malignancies.</p>Formula:C14H21N5O5Color and Shape:SolidMolecular weight:339.35N1-Methyl-2'-O-(2-methoxyethyl) guanosine
<p>N1-Methyl-2’-O-(2-methoxyethyl) guanosine, a purine nucleoside analog, exhibits broad antitumor activity against indolent lymphoid malignancies.</p>Formula:C14H21N5O6Color and Shape:SolidMolecular weight:355.352-(3-Methyln-propylidene hydrazino) adenosine
<p>2-(3-Methyln-propylidene hydrazino) adenosine: a purine analog with antitumor properties, inhibits DNA synthesis, induces apoptosis.</p>Formula:C15H23N7O4Color and Shape:SolidMolecular weight:365.39(R)-N-(2,3-Dihydro-1H-indenyl)-2-amino adenosine
<p>(R)-N-(2,3-Dihydro-1H-indenyl)-2-amino adenosine, a purine analog, targets lymphoid cancer via DNA synthesis inhibition and apoptosis.</p>Formula:C19H22N6O4Color and Shape:SolidMolecular weight:398.423'-Deoxy-N1-Methyl inosine
<p>3’-Deoxy-N1-Methyl inosine, a purine nucleoside analog, exhibits broad antitumor activity against indolent lymphoid malignancies.</p>Formula:C11H14N4O4Color and Shape:SolidMolecular weight:266.252'-O-Methyl-5-methyluridine 5'-triphosphate triethylammonium
<p>2’-O-Methyl-5-methyluridine 5’-triphosphate (triethylammonium), a thymidine analog, exhibits insertional activity in replicated DNA.</p>Formula:C29H64N5O15P3Color and Shape:SolidMolecular weight:815.766-O-Methyl-2'-O-methylinosine
<p>6-O-Methyl-2’-O-methylinosine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies.</p>Formula:C12H16N4O5Color and Shape:SolidMolecular weight:296.283'-O-DMT-N2-isobutyryl-2'-O-(2-methoxyethyl)guanosine
<p>3’-O-DMT-N2-isobutyryl-2’-O-(2-methoxyethyl)guanosine, a purine nucleoside analog, exhibits broad antitumor activity particularly against indolent lymphoid</p>Formula:C38H43N5O9Color and Shape:SolidMolecular weight:713.78N6-Methyl-2'-β-C-ethynyl adenosine
<p>N6-Methyl-2’-beta-C-ethynyl adenosine is a purine nucleoside analog.</p>Formula:C13H15N5O4Color and Shape:SolidMolecular weight:305.292'-Deoxy-2'-fluoroadenosine 5'-monophosphate triethylammonium
<p>2’-Deoxy-2’-fluoroadenosine 5’-monophosphate (triethylammonium) is a purine nucleoside analog with extensive antitumor properties, particularly effective</p>Formula:C22H43FN7O6PColor and Shape:SolidMolecular weight:551.592-Amino-6-O-methyl-2'-O-methyl purine riboside
<p>2-Amino-6-O-methyl-2’-O-methyl purine riboside, a purine nucleoside analog, exhibits broad antitumor activity, particularly against indolent lymphoid</p>Formula:C12H17N5O5Color and Shape:SolidMolecular weight:311.293'-β-C-Ethynyl-4-deoxyuridine
<p>3’-Beta-C-Ethynyl-4-deoxyuridine is a purine nucleoside analog.</p>Formula:C11H12N2O5Color and Shape:SolidMolecular weight:252.223'-β-C-Methyl-2-thiouridine
<p>3’-β-C-Methyl-2-thiouridine, a purine nucleoside analog, exhibits extensive antitumor activity, particularly against indolent lymphoid malignancies.</p>Formula:C10H14N2O5SColor and Shape:SolidMolecular weight:274.29
